Global Antibody Drug Conjugate Market Size study, by Technology (Cleavable Linker, Non-cleavable Linker, Linker less), by Application (Blood Cancer, Multiple Myeloma, Breast Cancer, Urothelial Cancer & Bladder Cancer, Others), and Regional Forecasts 2021-2027

BIZ4639269
200 Pages
August 2021
Pharmaceuticals

Download Sample Get Discount

Global Antibody Drug Conjugate Market is valued approximately at USD 4.3 Billion in 2020 and is anticipated to grow with a healthy growth rate of more than 23.0% over the forecast period 2021-2027. Antibody-drug conjugates is a kind of biopharmaceutical drugs which is designed as a targeted therapy while treating cancer. The global Antibody Drug Conjugate market is being driven by growing geriatric population base and increasing Incidence and Prevalence of Cancer. Furthermore, the presence of Strong Product Pipeline and advancement of technology, will provide new opportunities for the global Antibody Drug Conjugate industry. For instance, According to Globocan, in year 2020, incidences of cancer reached at 19.3 million, and the estimated deaths by cancer were around 9.96 million. The incidence of cancer is anticipated to rise and reach 21.9 million by year 2025 and 24.6 million by year 2030. As a result, increased in incidence of cancer will necessitate the use of more Antibody Drug Conjugate in delivering the treatment, which will serve as a catalyst for the Antibody Drug Conjugate industry in the future. However, unstable raw material prices and rigorous regulations regarding quality standards, may impede market growth over the forecast period of 2021-2027.

Asia Pacific, North America, Europe, Latin America, and Rest of the World are the key region considered for the regional analysis of global Antibody Drug Conjugate Market. Rising awareness about the current therapies, the presence of major players, and significant R&D expenditure makes the North America the leading region across the world in terms of market share. Whereas Asia pacific is also anticipated to exhibit the highest growth rate over the forecast period 2021-2027, due to the rising cancer prevalence in the region coupled with increasing investment in R&D in the region.

Major market player included in this report are:

Takeda Pharmaceutical Company Limited

F. Hoffmann-La Roche Ltd.

Pfizer, Inc.

Astrazeneca

Gilead Sciences, Inc.

Astellas Pharma

Seagen, Inc.

Daiichi Sankyo Company, Limited

GlaxoSmithKline Plc

ADC Therapeutics

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Technology:

Cleavable Linker

Non-cleavable Linker

Linker less

By Application:

Blood Cancer

Multiple Myeloma

Breast Cancer

Urothelial Cancer & Bladder Cancer

Others

By Region:

North America

U.S.

Canada

Europe

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019

Base year – 2020

Forecast period – 2021 to 2027.

Target Audience of the Global Antibody Drug Conjugate Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)

1.2.1. Antibody Drug Conjugate Market , by Region, 2019-2027 (USD Billion)

1.2.2. Antibody Drug Conjugate Market , by Technology, 2019-2027 (USD Billion)

1.2.3. Antibody Drug Conjugate Market , by Application, 2019-2027 (USD Billion)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Antibody Drug Conjugate Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Antibody Drug Conjugate Market Dynamics

3.1. Antibody Drug Conjugate Market Impact Analysis (2019-2027)

3.1.1. Market Drivers

3.1.1.1. Growing Geriatric Population Base

3.1.1.2. Increasing Incidence and Prevalence of Cancer

3.1.2. Market Restraint

3.1.2.1. High Manufacturing Cost of Antibody-Drug Conjugates and Challenges in Downstream Processing of ADCs

3.1.2.2. Stringent Reimbursement Policies for ADCs

3.1.3. Market Opportunities

3.1.3.1. Presence of Strong Product Pipeline

Chapter 4. Global Antibody Drug Conjugate Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Antibody Drug Conjugate Market , by Technology

5.1. Market Snapshot

5.2. Global Antibody Drug Conjugate Market by Technology, Performance - Potential Analysis

5.3. Global Antibody Drug Conjugate Market Estimates & Forecasts by Technology 2018-2027 (USD Billion)

5.4. Antibody Drug Conjugate Market , Sub Segment Analysis

5.4.1. Cleavable Linker

5.4.2. Non-cleavable Linker

5.4.3. Linker less

Chapter 6. Global Antibody Drug Conjugate Market , by Application

a. Market Snapshot

6.1. Global Antibody Drug Conjugate Market by Application, Performance - Potential Analysis

6.2. Global Antibody Drug Conjugate Market Estimates & Forecasts by Application 2018-2027 (USD Billion)

6.3. Antibody Drug Conjugate Market , Sub Segment Analysis

6.3.1. Blood Cancer

6.3.2. Multiple Myeloma

6.3.3. Breast Cancer

6.3.4. Urothelial Cancer & Bladder Cancer

6.3.5. Others

Chapter 7. Global Antibody Drug Conjugate Market , Regional Analysis

7.1. Antibody Drug Conjugate Market , Regional Market Snapshot

7.2. North America Antibody Drug Conjugate Market

7.2.1. U.S. Antibody Drug Conjugate Market

7.2.1.1. Technology breakdown estimates & forecasts, 2018-2027

7.2.1.2. Origin breakdown estimates & forecasts, 2018-2027

7.2.1.3. Application breakdown estimates & forecasts, 2018-2027

7.2.2. Canada Antibody Drug Conjugate Market

7.3. Europe Antibody Drug Conjugate Market Snapshot

7.3.1. U.K. Antibody Drug Conjugate Market

7.3.2. Germany Antibody Drug Conjugate Market

7.3.3. France Antibody Drug Conjugate Market

7.3.4. Spain Antibody Drug Conjugate Market

7.3.5. Italy Antibody Drug Conjugate Market

7.3.6. Rest of Europe Antibody Drug Conjugate Market

7.4. Asia-Pacific Antibody Drug Conjugate Market Snapshot

7.4.1. China Antibody Drug Conjugate Market

7.4.2. India Antibody Drug Conjugate Market

7.4.3. Japan Antibody Drug Conjugate Market

7.4.4. Australia Antibody Drug Conjugate Market

7.4.5. South Korea Antibody Drug Conjugate Market

7.4.6. Rest of Asia Pacific Antibody Drug Conjugate Market

7.5. Latin America Antibody Drug Conjugate Market Snapshot

7.5.1. Brazil Antibody Drug Conjugate Market

7.5.2. Mexico Antibody Drug Conjugate Market

7.6. Rest of The World Antibody Drug Conjugate Market

Chapter 8. Competitive Intelligence

8.1. Top Market Strategies

8.2. Company Profiles

8.2.1. Takeda Pharmaceutical Company Limited

8.2.1.1. Key Information

8.2.1.2. Overview

8.2.1.3. Financial (Subject to Data Availability)

8.2.1.4. Product Summary

8.2.1.5. Recent Developments

8.2.2. F. Hoffmann-La Roche Ltd.

8.2.3. Pfizer, Inc.

8.2.4. Astrazeneca

8.2.5. Gilead Sciences, Inc.

8.2.6. Astellas Pharma

8.2.7. Seagen, Inc.

8.2.8. Daiichi Sankyo Company, Limited

8.2.9. GlaxoSmithKline Plc

8.2.10. ADC Therapeutics

Chapter 9. Research Process

9.1. Research Process

9.1.1. Data Mining

9.1.2. Analysis

9.1.3. Market Estimation

9.1.4. Validation

• Publishing

9.2. Research Attributes

9.3. Research Assumption

List of Tables

TABLE 2. Global Antibody Drug Conjugate Market , report scope

TABLE 3. Global Antibody Drug Conjugate Market estimates & forecasts by region 2018-2027 (USD Billion)

TABLE 4. Global Antibody Drug Conjugate Market estimates & forecasts by Technology 2018-2027 (USD Billion)

TABLE 5. Global Antibody Drug Conjugate Market estimates & forecasts by origin 2018-2027 (USD Billion)

TABLE 6. Global Antibody Drug Conjugate Market estimates & forecasts by Application 2018-2027 (USD Billion)

TABLE 7. Global Antibody Drug Conjugate Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 8. Global Antibody Drug Conjugate Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 9. Global Antibody Drug Conjugate Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 10. Global Antibody Drug Conjugate Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 11. Global Antibody Drug Conjugate Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 12. Global Antibody Drug Conjugate Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 13. Global Antibody Drug Conjugate Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 14. Global Antibody Drug Conjugate Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 15. Global Antibody Drug Conjugate Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 16. Global Antibody Drug Conjugate Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 17. Global Antibody Drug Conjugate Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 18. Global Antibody Drug Conjugate Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 19. Global Antibody Drug Conjugate Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 20. Global Antibody Drug Conjugate Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 21. Global Antibody Drug Conjugate Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 22. Global Antibody Drug Conjugate Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 23. U.S. Antibody Drug Conjugate Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 24. U.S. Antibody Drug Conjugate Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 25. U.S. Antibody Drug Conjugate Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 26. Canada Antibody Drug Conjugate Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 27. Canada Antibody Drug Conjugate Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 28. Canada Antibody Drug Conjugate Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 29. UK Antibody Drug Conjugate Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 30. UK Antibody Drug Conjugate Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 31. UK Antibody Drug Conjugate Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 32. Germany Antibody Drug Conjugate Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 33. Germany Antibody Drug Conjugate Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 34. Germany Antibody Drug Conjugate Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 35. France Antibody Drug Conjugate Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 36. France Antibody Drug Conjugate Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 37. France Antibody Drug Conjugate Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 38. Spain Antibody Drug Conjugate Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 39. Spain Antibody Drug Conjugate Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 40. Spain Antibody Drug Conjugate Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 41. Italy Antibody Drug Conjugate Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 42. Italy Antibody Drug Conjugate Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 43. Italy Antibody Drug Conjugate Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 44. ROE Antibody Drug Conjugate Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 45. ROE Antibody Drug Conjugate Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 46. ROE Antibody Drug Conjugate Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 47. China Antibody Drug Conjugate Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 48. China Antibody Drug Conjugate Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 49. China Antibody Drug Conjugate Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 50. India Antibody Drug Conjugate Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 51. India Antibody Drug Conjugate Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 52. India Antibody Drug Conjugate Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 53. Japan Antibody Drug Conjugate Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 54. Japan Antibody Drug Conjugate Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 55. Japan Antibody Drug Conjugate Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 56. Australia Antibody Drug Conjugate Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 57. Australia Antibody Drug Conjugate Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 58. Australia Antibody Drug Conjugate Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 59. South Korea Antibody Drug Conjugate Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 60. South Korea Antibody Drug Conjugate Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 61. South Korea Antibody Drug Conjugate Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 62. ROPAC Antibody Drug Conjugate Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 63. ROPAC Antibody Drug Conjugate Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 64. ROPAC Antibody Drug Conjugate Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 65. Brazil Antibody Drug Conjugate Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 66. Brazil Antibody Drug Conjugate Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 67. Brazil Antibody Drug Conjugate Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 68. Mexico Antibody Drug Conjugate Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 69. Mexico Antibody Drug Conjugate Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 70. Mexico Antibody Drug Conjugate Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 71. ROLA Antibody Drug Conjugate Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 72. ROLA Antibody Drug Conjugate Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 73. ROLA Antibody Drug Conjugate Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 74. ROW Antibody Drug Conjugate Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 75. ROW Antibody Drug Conjugate Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 76. ROW Antibody Drug Conjugate Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 77. List of secondary sources used in the study of global Antibody Drug Conjugate Market .

TABLE 78. List of primary sources used in the study of global Antibody Drug Conjugate Market .

TABLE 79. Years considered for the study.

TABLE 80. Exchange rates considered.

Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Global Antibody Drug Conjugate Market Size study, by Technology (Cleavable Linker, Non-cleavable Linker, Linker less), by Application (Blood Cancer, Multiple Myeloma, Breast Cancer, Urothelial Cancer & Bladder Cancer, Others), and Regional Forecasts 2021-2027

Contact Us

Drop Us an email at

Similar Reports

Client Testimonials

Maria

David

Sara